Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FLUBIODEM

Financiado

Fluid Biomarkers for Neurodegenerative Dementias

Critical to our understanding of Alzheimer’s disease (AD) and other neurodegenerative dementias (NDDs), as well as to finding disease-modifying therapies, is the development of biomarkers for the underlying disease processes. To f... ver más

31/08/2027

UGOT - GOETEBORGS...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

GOETEBORGS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-08-04

ERC-2021-ADG: ERC ADVANCED GRANTS Scope:Objectives

I+D

Cerrada hace 3 años

0% 100% 100%

1 Participantes

UGOT - GOETEBORGS UNIVERSITE...

2.42M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2020-117656RB-I00 DESARROLLO DE NUEVAS HERRAMIENTAS DIAGNOSTICAS Y ESTRATEGIAS... 316K€ Cerrado

CTQ2014-59544-P UNA PERSPECTIVA ATOMISTICA DE LA DETECCION, TOXICIDAD Y AGRE... 143K€ Cerrado

PID2020-118386RA-I00 LOCALIZACION DE CAMBIOS CEREBRALES EL LA ENFERMEDAD DE ALZHE... 33K€ Cerrado

TEC2009-14587-C03-01 NEUROBIN: BIOMARCADORES DE NEUROIMAGEN PARA ENFERMEDADES NEU... 108K€ Cerrado

EQC2018-005332-P Detección precoz de enfermedades neurodegenerativas con inmu... 67K€ Cerrado

PID2021-123087OB-I00 SISTEMAS INTELIGENTES BASADOS EN BIOMARCADORES PARA SALUD 120K€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2022-08-04
Fecha Fin: 2027-08-31

Líder del proyecto

GOETEBORGS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto Critical to our understanding of Alzheimer’s disease (AD) and other neurodegenerative dementias (NDDs), as well as to finding disease-modifying therapies, is the development of biomarkers for the underlying disease processes. To facilitate improved diagnostics and drug discovery, we have developed methods to measure markers of amyloid and tau pathology, central and peripheral nervous system injury, astrocytic and microglial activation, as well as neuroinflammation. Our most exciting advancement in this field so far is the development of phosphorylated tau assays sensitive enough to measure this protein in plasma to detect AD pathology in the brain and to allow for disease stratification and monitoring based on AD pathology. I now propose to develop new high-throughput biomarker tools that will enable the analysis of large cohort studies combining clinical, imaging, genetic and biomarker data to provide truly comprehensive molecular disease phenotypes that will inform interventions, drug discovery and translational research, clinical trial stratification, detection of risk and resilience factors (lifestyle-related, as well as genetic), and ultimately drive the quest towards clinically accessible personalised medicine in the NDD field. A large part of the research efforts will be focused on discovering new biomarkers for TDP-43 and α-synuclein pathologies, non-AD tau pathology, and lysosomal and synaptic dysfunction, through general and targeted proteomics on CSF samples, and through employing a novel cell type-biased tandem mass tag proteomics workflow to discover biomarkers related to neuronal, astrocytic, and microglial cells, and their different activation states. Promising CSF biomarkers will be examined in blood; biomarker candidates that are measurable in this matrix and correlate with CSF will be developed into sensitive and specific blood tests using cutting-edge technology, as we have previously done for Aβ40, Aβ42, T-tau, P-tau, NfL, and GFAp.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores